Newsroom
Please find below our latest press releases, events, and articles.
SEPTEMBER 2022
Press article
CF NEWS article about QUINTEN:
"Quinten soigne son intelligence artificielle."
SEPTEMBER 2022
HEALTH TECH / Health data
Investment in QUINTEN, a developer of algorithms and AI solutions for data processing and enhancement for all healthcare players
JUNE 2022
Press article
BIOTECH FINANCE article about TECHLIFE CAPITAL:
"Growth Venture - TechLife Capital marie santé et tech."
APRIL 2022
Press article
DÉCIDEURS MAGAZINE article about MITEM:
"Le laboratoire Mitem Pharma lève 10 millions d’euros auprès du fonds TechLife Capital."
APRIL 2022
Press article
CF NEWS article about MITEM:
"MITEM veut accélérer son développement et trouve écho auprès de Techlife qui injecte 10 M€."
APRIL 2022
HEALTHCARE / Pharmaceutical industry
Investment in MITEM Pharma, an agile pharmaceutical laboratory dedicated to Medicines of Major Therapeutics Interests
JULY 2021
HEALTH TECH / Health Data
Investment in MyData-Trust, a provider of outsourced data protection services and solutions for the biotech and pharma companies
JUNE 2021
HEALTHCARE / Pharmaceutical Industry
Investment in Flash Therapeutics, a high-end designer and manufacturer of viral vectors for biotech companies (critical products in gene therapy, cell therapy, mRNA therapies)
October 2020
Press Article
CFNews article about TECHLIFE CAPITAL: « TechLife Capital se lance dans le growth en visant le numérique et la santé »
SEPTEMBER 2020
TECHNOLOGY / Software
Acquisition of Maxxing, an editor of customer relationship and loyalty management software (SaaS)
SEPTEMBER 2020
Press Article
Private Equity Magazine article about TECHLIFE CAPITAL: « TechLife Capital creuse les filières d’avenir en santé et en technologie »
JULY 2020
Financing innovation Label
TechLife Capital receives a Financing Innovation label from the French Ministry of Economy (Tibi Initiative).
MARCH 2020
HEALTHCARE / Medical Services
Launch of XPath, a consolidation platform in cancer diagnosis services and investment in the two first laboratories (South East)